Search research articles
Contact Us
Filters
Showing results (81-90 of 161) with videos related to
Page
of 17
Sort By:
International Journal of Cancer
|
July 17, 2015
High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers
Barry M Dent, Laura F Ogle, Rachel L O'Donnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2009
Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma
Rachel A Daniel, Agata L Rozanska, Huw D Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2022
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
Robert Jones, Ruth Plummer, Victor Moreno, et al.
Investigational New Drugs
|
June 13, 2012
Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors
Christophe Massard, Jane Margetts, Nadia Amellal, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 11, 2021
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer
Ruth Plummer, Emma Dean, Hendrik-Tobias Arkenau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2010
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors
Timothy A Yap, Laura Vidal, Jan Adam, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 30, 2023
Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trial
Vicky Coyle, Caroline Forde, Danny F McAuley, et al.
British Journal of Cancer
|
April 18, 2019
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours
Gabriel Mak, Jean-Charles Soria, Sarah P Blagden, et al.
Cancer Chemotherapy and Pharmacology
|
August 6, 2015
Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours
Ruth Plummer, Helen Swaisland, Karin Leunen, et al.
British Journal of Cancer
|
May 17, 2025
The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study
Timothy A Yap, Patricia LoRusso, Rowan E Miller, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 161) with videos related to
Sort By:
Page
of 17
International Journal of Cancer
|
July 17, 2015
High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers
Barry M Dent, Laura F Ogle, Rachel L O'Donnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2009
Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma
Rachel A Daniel, Agata L Rozanska, Huw D Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2022
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
Robert Jones, Ruth Plummer, Victor Moreno, et al.
Investigational New Drugs
|
June 13, 2012
Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors
Christophe Massard, Jane Margetts, Nadia Amellal, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 11, 2021
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer
Ruth Plummer, Emma Dean, Hendrik-Tobias Arkenau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2010
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors
Timothy A Yap, Laura Vidal, Jan Adam, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 30, 2023
Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trial
Vicky Coyle, Caroline Forde, Danny F McAuley, et al.
British Journal of Cancer
|
April 18, 2019
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours
Gabriel Mak, Jean-Charles Soria, Sarah P Blagden, et al.
Cancer Chemotherapy and Pharmacology
|
August 6, 2015
Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours
Ruth Plummer, Helen Swaisland, Karin Leunen, et al.
British Journal of Cancer
|
May 17, 2025
The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study
Timothy A Yap, Patricia LoRusso, Rowan E Miller, et al.
Page
of 17